Principles, techniques, and applications of T2*-based MR imaging and its special applications

Radiographics

Volumn 29, Issue 5, 2009, Pages 1433-1449

  Chavhan, Govind B ^a   Babyn, Paul S ^a   Thomas, Bejoy ^a   Shroff, Manohar M ^a   Mark Haacke, E ^b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTHROPATHY; BRAIN DISEASE; HUMAN; IMAGE ENHANCEMENT; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; SCINTIGRAPHY;

BRAIN DISEASES; HUMANS; IMAGE ENHANCEMENT; JOINT DISEASES; MAGNETIC RESONANCE IMAGING; PERFUSION IMAGING;

EID: 70349901405     PISSN: 02715333     EISSN: 15271323     Source Type: Journal    
DOI: 10.1148/rg.295095034     Document Type: Article

References (47)

1. Mugler JP III. Basic principles. In: Edelman RR, Hesselink JR, Zlatkin MB, Crues JV, eds. Clinical magnetic resonance imaging. 3rd ed. Philadelphia, Pa: Saunders Elsevier, 2006; 23-57.
2. Nitz WR, Reimer P. Contrast mechanisms in MR imaging. Eur Radiol 1999;9:1032-1046.
3. Hendrick RE. Image contrast and noise. In: Stark DD, Bradley WG, eds. Magnetic resonance imaging. 3rd ed. St Louis, Mo: Mosby, 1999; 43-68.
4. Haacke EM, Tkach JA, Parrish TB. Reduction of T2* dephasing in gradient field-echo imaging. Radiology 1989;170:457-462.
5. Frahm J, Haenicke W. Rapid scan techniques. In: Stark DD, Bradley WG, eds. Magnetic resonance imaging. 3rd ed. St Louis, Mo: Mosby, 1999; 87-124.
6. Chavhan GB, Babyn PS, Jankharia BG, Cheng HL, Shroff MM. Steady-state MR imaging sequences: physics, classification, and clinical applications. RadioGraphics 2008;28:1147-1160.
7. Edelman RR, Dunkle EE, Wei Li, Kissinger KV, Thangaraj K. Practical considerations and image optimization. In: Edelman RR, Hesselink JR, Zlatkin MB, Crues JV, eds. Clinical magnetic resonance imaging. 3rd ed. Philadelphia, Pa: Saunders Elsevier, 2006; 58-104.
8. Elster AD. Gradient-echo MR imaging: techniques and acronyms. Radiology 1993;186:1-8.
9. Tsushima Y, Endo K. Hypointensities in the brain on T2*-weighted gradient-echo magnetic resonance imaging. Curr Probl Diagn Radiol 2006;35: 140-150.
10. Thamburaj K, Radhakrishnan VV, Thomas B, Nair S, Menon G. Intratumoral microhemorrhages on T2*-weighted gradient-echo imaging helps differentiate vestibular schwannoma from meningioma. AJNR Am J Neuroradiol 2008;29:552-557.
11. Tosaka M, Sato N, Hirato J, et al. Assessment of hemorrhage in pituitary macroadenoma by T2*weighted gradient-echo MR imaging. AJNR Am J Neuroradiol 2007;28:2023-2029.
12. Rovira A, Orellana P, Alvarez-Sabin J, et al. Hyperacute ischemic stroke: middle cerebral artery susceptibility sign at echo-planar gradient-echo MR imaging. Radiology 2004;232:466-473.
13. Ishiyama K, Hashimoto M, Izumi J, et al. Tumor-liver contrast and subjective tumor conspicuity of respiratory-triggered T2-weighted fast spin-echo sequence compared with T2*-weighted gradient recalled-echo sequence for ferucarbotran-enhanced magnetic resonance imaging of hepatic malignant tumors. J Magn Reson Imaging 2008;27:1322-1326.
14. Tonan T, Fujimoto K, Azuma S, et al. Evaluation of small dysplastic nodules and well-differentiated hepatocellular carcinomas with ferucarbotranenhanced MRI in a 1.0-T MRI unit: utility of T2*-weighted gradient echo sequences with an intermediate-echo time. Eur J Radiol 2007;64:133-139.
15. Reichenbach JR, Venkatesan R, Schillinger DJ, Kido DK, Haacke EM. Small vessels in the human brain: MR venography with deoxyhemoglobin as an intrin-sic contrast agent. Radiology 1997;204:272-277.
16. Reichenbach JR, Haacke EM. High-resolution BOLD venographic imaging: a window into brain function. NMR Biomed 2001;14:453-467.
17. Yamada N, Imakita S, Sakuma T, Takamiya M. Intracranial calcification on gradient-echo phase image: depiction of diamagnetic susceptibility. Radiology 1996;198:171-178.
18. Haacke EM, Xu Y, Cheng YC, Reichenbach JR. Susceptibility weighted imaging (SWI). Magn Reson Med 2004;52:612-618.
19. Tong KA, Ashwal S, Holshouser BA, et al. Hemorrhagic shearing lesions in children and adolescents with posttraumatic diffuse axonal injury: improved detection and initial results. Radiology 2003;227: 332-339.
20. Sehgal V, Delproposto Z, Haacke EM, et al. Clinical applications of neuroimaging with susceptibilityweighted imaging. J Magn Reson Imaging 2005;22: 439-450.
21. Thomas B, Somasundaram S, Thamburaj K, et al. Clinical applications of susceptibility weighted MR imaging of the brain: a pictorial review. Neuroradiology 2008;50:105-116.
22. Li D, Waight DJ, Wang Y. In vivo correlation between blood T2* and oxygen saturation. J Magn Reson Imaging 1998;8:1236-1239.
23. Rauscher A, Sedlacik J, Barth M, et al. Magnetic susceptibility-weighted MR phase imaging of the human brain. AJNR Am J Neuroradiol 2005;26: 736-742.
24. Gupta RK, Rao SB, Rajan J, et al. Differentiation of calcification from chronic hemorrhage with corrected gradient echo phase imaging. J Comput Assist Tomogr 2001;25:698-704.
25. Haacke EM, Cheng NY, House MJ, et al. Imaging iron stores in the brain using magnetic resonance imaging. Magn Reson Imaging 2005;23:1-25.
26. Haacke EM, Ayaz M, Khan A, et al. Establishing a baseline phase behavior in magnetic resonance imaging to determine normal vs abnormal iron content in the brain. J Magn Reson Imaging 2007;26: 256-264.
27. Tong KA, Ashwal S, Obenaus A, Nickerson JP, Kido D, Haacke EM. Susceptibility-weighted MR imaging: a review of clinical applications in children. AJNR Am J Neuroradiol 2008;29:9-17.
28. Cha S, Knopp EA, Johnson G, Wetzel SG, Litt AW, Zagzag D. Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging. Radiology 2002;223:11-29.
29. Alsop D. Perfusion imaging of the brain. In: Edelman RR, Hesselink JR, Zlatkin MB, Crues JV, eds. Clinical magnetic resonance imaging. 3rd ed. Philadelphia, Pa: Saunders Elsevier, 2006; 333-376.
30. Cha S. Update on brain tumor imaging: from anatomy to physiology. AJNR Am J Neuroradiol 2006;27:475-487.
31. Lemort M, Canizares-Perez AC, Van der Stappen A, Kampouridis S. Progress in magnetic resonance imaging of brain tumors. Curr Opin Oncol 2007;19: 616-622.
32. Provenzale JM, Mukundan S, Barboriak DP. Diffusion-weighted and perfusion MR imaging for brain tumor characterization and assessment of treatment response. Radiology 2006;239:632-649.
33. Law M, Young RJ, Babb JS, et al. Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Radiology 2008;247:490-499.
34. Emblem KE, Scheie D, Due-Tonnessen P, et al. Histogram analysis of MR imaging-derived cerebral blood volume maps: combined glioma grading and identification of low-grade oligodendroglial subtypes. AJNR Am J Neuroradiol 2008;29:1664-1670.
35. Karonen JO, Liu Y, Vanninen RL, et al. Combined perfusion- and diffusion-weighted MR imaging in acute ischemic stroke during the 1st week: a longitudinal study. Radiology 2000;217:886-894.
36. Rowley HA, Roberts TP. Clinical perspectives in perfusion: neuroradiologic applications. Top Magn Reson Imaging 2004;15:28-40.
37. Uludag K, Dubowitz DJ, Buxton RB. Basic principles of functional MRI. In: Edelman RR, Hesselink JR, Zlatkin MB, Crues JV, eds. Clinical magnetic resonance imaging. 3rd ed. Philadelphia, Pa: Saunders Elsevier, 2006; 249-287.
38. Moritz C, Haughton V. Functional MR imaging: paradigms for clinical preoperative mapping. Magn Reson Imaging Clin N Am 2003;11:529-542.
39. Petrella JR, Shah LM, Harris KM, et al. Preoperative functional MR imaging localization of language and motor areas: effect on therapeutic decision making in patients with potentially resectable brain tumors. Radiology 2006;240:793-802.
40. Gossuin Y, Muller RN, Gillis P. Relaxation induced by ferritin: a better understanding for an improved MRI iron quantification. NMR Biomed 2004;17: 427-432.
41. Wood JC, Ghugre N. MRI assessment of excess iron in thalassemia, sickle cell disease and other iron overload diseases. Hemoglobin 2008;32:85-96.
42. Alustiza JM, Artetxe J, Castiella A, et al. MR quantification of hepatic iron concentration. Radiology 2004;230:479-484.
43. Argyropoulou MI, Astrakas L. MRI evaluation of tissue iron burden in patients with beta-thalassemia major. Pediatr Radiol 2007;37:1191-1200.
44. Gandon Y, Olivie D, Guyader D, et al. Non-invasive assessment of hepatic iron stores by MRI. Lancet 2004;363:357-362.
45. Gandon Y. Hemochromatosis and MRI. Department of Medical Imaging, University Hospital of Rennes Web site. http://www.radio.univ-rennes1.fr/HomeEN.html. Updated June 10, 2001. Accessed November 1, 2008.
46. St Pierre TG, Clark RR, Chua-anusorn W, et al. Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance. Blood 2005;105:855-861.
47. Anderson LJ, Holden S, Davis B, et al. Cardiovascular T2-star (T2*) MR for the early diagnosis of myocardial iron overload. Eur Heart J 2001;22: 2171-2179.